Answer
Jul 31, 2025 - 09:44 AM
Genvoya includes cobicistat because it acts as a pharmacokinetic enhancer, specifically boosting the effectiveness of the antiretroviral drug elvitegravir. By inhibiting the enzyme CYP3A, cobicistat increases elvitegravir's concentration in the bloodstream, allowing for once-daily dosing and improved antiviral activity against HIV.
